Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action

BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the study was to evaluate the outcome of severe COVID-19 patients basing on prothrombotic risk factors (i.e. D-dimer). We also evaluated the impact of different doses of low m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thromb Res
Hlavní autoři: Pavoni, Vittorio, Gianesello, Lara, Pazzi, Maddalena, Stera, Caterina, Meconi, Tommaso, Frigieri, Francesca Covani
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Ltd. 2020
Témata:
Full Length Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487146/
https://ncbi.nlm.nih.gov/pubmed/32977129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2020.09.013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky